-
Standardized Interpretation Pipelines Will Be Essential For Genomic Medicine
Bio-IT World Contributed Commentary | Next-generation sequencing continues to offer new hope for scientists and clinicians focused on everything from rare disease to cancer. Still, the clinical application of genomics could use some crucial improvements— perhaps none more urgent than standardized automated tools for genome interpretation.
Sep 29, 2017
-
The Zika Virus Grew Deadlier With A Small Mutation Study Suggests
The New York Times | A single variation in its DNA may have helped equip the virus to attack fetal cells, contributing to a surge of birth defects in Latin America.
Sep 28, 2017
-
As Consumer DNA Testing Grows, Two States Resist
MIT Technology Review | Maryland and New York still restrict who can order genetic tests and how companies can market them.
Sep 28, 2017
-
Celgene’s Big Data IQ
Bio-IT World | In recent years, Celgene has been doubling down on its information analytics capabilities, and in January it launched an internal big data platform to more cohesively manage data to drive decision-making from pre-clinical research through commercialization.
Sep 28, 2017
-
The drug-makers guide to the galaxy
Nature News & Comment | How machine learning and big data are helping chemists search the vast chemical universe for better medicines.
Sep 26, 2017
-
Deep Genomics Raises $13 Million To Develop Genetic Medicines
Bio-IT World Brief | Deep Genomics received a USD $13 million equity investment led by Khosla Ventures. They are accompanied by early stage investment firm True Ventures. In the next three years, Deep Genomics will use its platform to unlock new classes of anti-sense oligonucleotide therapies that were previously inaccessible, and advance them for clinical evaluation.
Sep 25, 2017
-
Congenica, PerkinElmer, Illumina, And More: News From September 2017
Bio-IT World | September featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Congenica, PerkinElmer, Illumina, and more.
Sep 25, 2017
-
Jackson Lab Files Federal Complaint, Accusing Chinese University Of Selling Its Mice
Hartford Courant | The Jackson Laboratory is suing to stop Nanjing University, whom it accuses of selling offspring of the genomics center’s mice used for research.
Sep 22, 2017
-
Even At $500K, Gene Therapy Could Be A Bargain For Some Diseases
MIT Technology Review | A one-time gene therapy that costs half a million dollars sounds crazy until you add up what it costs to treat some diseases over a lifetime.
Sep 21, 2017
-
CRISPR Used To Peer Into Human Embryo's First Days
Nature News & Comment | Gene-edited embryos enable researchers to unpick role of a crucial gene, with more studies likely to follow.
Sep 20, 2017
-
Edico Genome’s DRAGEN Now Available On Illumina’s BaseSpace Sequence Hub
Bio-IT World Brief | Edico Genome today announced the availability of its DRAGEN Bio-IT Platform on Illumina’s BaseSpace Sequence Hub, enabling users to now run DRAGEN instances to enhance the accuracy and speed of their secondary analysis of next-generation sequencing data.
Sep 19, 2017
-
Amazon Announces Per-Second Billing For EC2 Instances And EBS Volumes
AWS Blog | Amazon has announced that, effective October 2, usage of Linux instances that are launched in On-Demand, Reserved, and Spot form will be billed in one-second increments. Similarly, provisioned storage for EBS volumes will be billed in one-second increments. Per-second billing also applies to Amazon EMR and AWS Batch.
Sep 18, 2017
-
Earlham Institute Presents Sequence Alignment Using Optalysys’ Optical Correlator Computing System
Bio-IT World | 2017 Best Practices Awards | The Earlham Institute are working with Optalysys to apply Optalysys’ optical computing system to life science applications. The first release of the computing system is scheduled for early 2018, which both organizations say will be capable of performing a number of different DNA-based local sequence alignment applications.
Sep 18, 2017
-
Moderna Ends “Venture” Experiment, Dissolves Four Startups
Xconomy | Moderna Therapeutics announced today that it is ending the experiment to hatch startups as wholly-owned subsidaries, bringing all their experimental drugs back into the Moderna nest.
Sep 14, 2017
-
Brainin Joins WuXi NextCODE, Prioritizes Actionability Of Genome
Bio-IT World | WuXi NextCODE today announced the appointment of Rob Brainin as executive vice president and chief operating officer. Brainin joins the company from Illumina, where he was vice president and general manager of life sciences and applied genomics.
Sep 13, 2017
-
IBM Expands Certified Public Cloud Infrastructure For SAP HANA
Bio-IT World Brief | IBM today announced the availability of new SAP-certified bare metal servers for SAP HANA platform deployments in the IBM Cloud and new configurations for VMware environments. The new cloud infrastructure-as-a-service solutions are designed to give enterprises the power and performance they need to manage their mission-critical applications running on SAP HANA.
Sep 12, 2017
-
Alexion Cutting 600 Jobs And Moving Headquarters In Major Shakeup
STAT | Alexion, once one of biotech's biggest success stories, is eliminating 20% of its global workforce as it struggles to map out a brighter future.
Sep 12, 2017
-
Long-Read Sequencing Data Enables Structural Variant Discovery For Clinical And Disease Research
Bio-IT World Contributed Commentary | The advent of single molecule, real-time sequencing, with average read lengths exceeding 12 kb, has allowed scientists to reliably detect structural variation for the first time. These latest studies have shown that previous human genome data sets have dramatically underrepresented the number of structural variants—along with their effect on health and disease.
Sep 11, 2017
-
Amid Setback Researchers Forge Ahead with “Off-the-Shelf” Immune Cells to Treat Cancer
MIT Technology Review | The approach could treat patients in dire need faster at a lower price, but major questions remain about safety.
Sep 8, 2017
-
Patients Without Traditional Cancer Screening Find Allies In Maccabi And Medial EarlySign
Bio-IT World | 2017 Best Practices Awards | Maccabi Healthcare System is using Medial EarlySign’s clinical decision support tool to find colon cancer patients among individuals who didn’t go through traditional channels for screening.
Sep 8, 2017